Concepedia

J. Flanagan

JF

Statistics

Publications

5

Citations

762

H-Index

5

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

J. Flanagan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cartilage breakdown, and osteoarthritis.

Publications per year

1997–2014

5

Publications

5

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Michael W. Lark, E K Bayne, J. Flanagan et al. · Journal of Clinical Investigation · 1997 · 472 citations · Full text

, , +17

Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction

John S. Mudgett, Nancy I. Hutchinson, Nicole Chartrain et al. · Arthritis & Rheumatism · 1998 · 202 citations

, , +17

Palliative performance scale and survival among outpatients with advanced cancer

Jeff Myers, Audrey Kim, J. Flanagan et al. · Supportive Care in Cancer · 2014 · 47 citations

, , +11

Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist

E K Bayne, J. Flanagan, Qing Shao et al. · Journal of Immunological Methods · 2009 · 26 citations

, , +17

Susceptibility of stromelysin 1‐deficient mice to collagen‐induced arthritis and cartilage destruction

John S. Mudgett, Nancy I. Hutchinson, Nicole Chartrain et al. · Arthritis & Rheumatism · 1998 · 15 citations

, , +17

1–5 of 5